Long-Term Safety of Filgotinib in Patients with Psoriatic Arthritis, Week 52 Safety Data from a Phase 2 Open-Label Extension Study

被引：0

作者：

Gladman, Dafna ^{[1
]}

Coates, Laura ^{[2
]}

Mease, Philip ^{[3
,4
]}

van den Bosch, Filip ^{[5
]}

Rychlewska-Hanczewska, Anna ^{[6
]}

Tasset, Chantal ^{[7
]}

Meuleners, Luc ^{[7
]}

Trivedi, Mona ^{[8
]}

Guo, Ying ^{[8
]}

Besuyen, Robin ^{[7
]}

Helliwell, Philip ^{[9
]}

机构：

[1] Univ Toronto, Krembil Res Inst, Dept Med, Toronto Western Hosp, Toronto, ON, Canada

[2] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England

[3] Providence St Joseph Hlth, Swedish Med Ctr, Seattle, WA USA

[4] Univ Washington, Sch Med, Seattle, WA USA

[5] Ghent Univ Hosp, Ghent, Belgium

[6] AI Ctr Med, Poznan, Poland

[7] Galapagos NV, Mechelen, Belgium

[8] Gilead Sci USA, Foster City, CA USA

[9] Univ Leeds, Leeds, W Yorkshire, England

来源：

JOURNAL OF RHEUMATOLOGY | 2020年 / 47卷 / 07期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1066 / 1067

页数：2

共 50 条

[1] Long-term Safety of Filgotinib in Patients with Psoriatic Arthritis, Week 52 Safety Data from a Phase 2 Open-Label Extension Study
Coates, Laura
Mease, Philip
Gladman, Dafna
Van den Bosch, Filip
Rychlewska-Hanczewska, Anna
Tasset, Chantal
Meuleners, Luc
Trivedi, Mona
Gao, Jingjing
Besuyen, Robin
Helliwell, Philip
[J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71
[2] LONG-TERM SAFETY OF FILGOTINIB IN PATIENTS WITH PSA: WEEK 52 SAFETY DATA FROM A PHASE 2 OPENLABEL EXTENSION STUDY
Coates, Laura
Mease, Philip
Gladman, Dafna
Van den Bosch, Filip
Rychlewska-Hanczewska, Anna
Tasset, Chantal
Meuleners, Luc
Trivedi, Mona
Guo, Ying
Besuyen, Robin
Helliwell, Philip
[J]. RHEUMATOLOGY, 2020, 59
[3] Long Term Safety of Filgotinib in the Treatment of Rheumatoid Arthritis: Week 84 Data from a Phase 2b Open-Label Extension Study
Genovese, Mark C.
Kavanaugh, Arthur
Winthrop, Kevin
Greenwald, Maria
Ponce, Lucia
Enriquez Sosa, Favio
Stanislavchuk, Mykola
Mazur, Minodora
Spindler, Alberto
Cseuz, Regina
Nikulenkova, Natalya
Glowacka-Kulesz, Maria
Szombati, Istvan
Dudek, Anna
Mozaffarian, Neelufar
Greer, Joy
Ding, Xiao
Harrison, Pille
Van der Aa, Annegret
Westhovens, Rene
Alten, Rieke
[J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69
[4] LONG TERM SAFETY OF FILGOTINIB IN THE TREATMENT OF RHEUMATOID ARTHRITIS: WEEK 108 DATA FROM A PHASE 2B OPEN-LABEL EXTENSION STUDY
Westhovens, R.
Alten, R.
Winthrop, K.
Greenwald, M.
Ponce, L.
Enriquez-Sosa, F.
Stanislavchuk, M.
Mazur, M.
Spindler, A.
Cseuz, R.
Nikulenkova, N.
Glowacka-Kulesz, M.
Szombati, I.
Dudek, A.
Mozaffarian, N.
Greer, J.
Kunder, R.
An, D.
Harrison, P.
Van der Aa, A.
Kavanaugh, A.
Genovese, M.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 960 - 961
[5] Rheumatoid Arthritis Treatment with Filgotinib: Week 132 Safety Data from a Phase 2b Open-Label Extension Study
Kavanaugh, Arthur
Genovese, Mark C.
Winthrop, Kevin
Creenwald, Maria
Ponce, Lucia
Sosa, Favio Enriquez
Stanislavchuk, Mykola
Mazur, Minodora
Spindler, Alberto
Cseuz, Regina
Nikulenkova, Natalya
Glowacka-Kulesz, Maria
Szombati, Istvan
Dudek, Anna
Mozaffarian, Neelufar
Greer, Joy
Kunder, Rebecca
An, Di
Meulener, Luc
Besuyen, Robin
Alten, Rieke
Westhovens, Rene
[J]. ARTHRITIS & RHEUMATOLOGY, 2018, 70
[6] Rheumatoid arthritis treatment with filgotinib: Week 156 safety and efficacy data from a phase 2b open-label extension study
Besuyen, R.
Kavanaugh, A.
Westhovens, R.
Winthrop, K.
Lee, S.
Greer, J.
DeZure, A.
An, D.
Ye, L.
Sundy, J.
Meuleners, L.
Alten, R.
Genovese, M.
[J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 : S452 - S452
[7] Rheumatoid Arthritis Treatment with Filgotinib: Week 156 Safety and Efficacy Data from a Phase 2b Open-Label Extension Study
Kavanaugh, Arthur
Westhovens, Rene
Winthrop, Kevin
Lee, Susan
Greer, Joy
DeZure, Adam
An, Di
Ye, Lei
Sundy, John
Besuyen, Robin
Meuleners, Luc
Alten, Rieke
Genovese, Mark
[J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71
[8] THE EFFECT OF FILGOTINIB ON ENTHESITIS: 100-WEEK DATA FROM AN OPEN-LABEL EXTENSION STUDY IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS
Helliwell, P.
Coates, L. C.
Van den Bosch, F.
Gladman, D. D.
Gheyle, L.
Trivedi, M.
Alani, M.
Le Brun, F. O.
Besuyen, R.
Mease, P. J.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 792 - 793
[9] Long-term safety and efficacy of erenumab in patients with chronic migraine: Results from a 52-week, open-label extension study
Tepper, Stewart J.
Ashina, Messoud
Reuter, Uwe
Brandes, Jan Lewis
Dolezil, David
Silberstein, Stephen D.
Winner, Paul
Zhang, Feng
Cheng, Sunfa
Mikol, Daniel D.
[J]. CEPHALALGIA, 2020, 40 (06) : 543 - 553
[10] Baricitinib, an Oral Janus Kinase Inhibitor, in the Treatment of Rheumatoid Arthritis: 52 Week Safety and Efficacy in an Open-Label, Long-Term Extension Study
Baker, Milton
Chalabi, Youb
Genovese, Mark
Taylor, Peter
Schlichting, Douglas
Beattie, Scott
Macias, William
Keystone, Edward
[J]. JOURNAL OF RHEUMATOLOGY, 2014, 41 (07) : 1505 - 1505

← 1 2 3 4 5 →